MyAverix Finance
HK · Healthcare
China Grand Pharmaceutical and Healthcare Holdings Ltd (0512)
Drug Manufacturers - Specialty & Generic
China Grand Pharmaceutical and Healthcare Holdings Ltd (0512) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $19.12B, P/E ratio is 15.60, net margin is 10.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 0512
China Grand Pharmaceutical and Healthcare Holdings Ltd (0512) — FAQ
What is China Grand Pharmaceutical and Healthcare Holdings Ltd's market cap?
China Grand Pharmaceutical and Healthcare Holdings Ltd (0512) has a reported market cap of $19.12B (data as of 2026-05-21).
What is 0512's P/E ratio?
The price-to-earnings (P/E) ratio for China Grand Pharmaceutical and Healthcare Holdings Ltd (0512) is 15.60 (data as of 2026-05-21).
Does China Grand Pharmaceutical and Healthcare Holdings Ltd pay a dividend?
Dividend yield is not available in the current snapshot for China Grand Pharmaceutical and Healthcare Holdings Ltd (0512). Check the MyAverix Finance app for the latest dividend data.
What sector is China Grand Pharmaceutical and Healthcare Holdings Ltd in?
China Grand Pharmaceutical and Healthcare Holdings Ltd (0512) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 0512 listed on?
0512 is listed on HK.
What is China Grand Pharmaceutical and Healthcare Holdings Ltd's net margin?
China Grand Pharmaceutical and Healthcare Holdings Ltd (0512) reports a net margin of 10.1% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.